fundvisualizer.com

Northern International EquityNOIGX

Performance (before sales charge)

As of 09/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2024
Stock
0.00%
Non-U.S. Stock
98.12%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.14%
Other
0.73%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2024

Basic materials

6.83%

Consumer cyclical

11.08%

Financial services

20.26%

Real estate

2.42%

Consumer defensive

7.95%

Health care

11.67%

Utilities

2.92%

Communication services

3.81%

Energy

4.99%

Industrials

17.08%

Technology

9.13%

Top 10 holdings

As of 09/30/2024

Novartis AG Registered Shares
2.16%
Shell PLC
1.69%
Roche Holding AG
1.54%
ABB Ltd
1.41%
ITOCHU Corp
1.40%
GSK PLC
1.35%
Manulife Financial Corp
1.35%
ANZ Group Holdings Ltd
1.34%
Banco Bilbao Vizcaya Argentaria SA
1.28%
KDDI Corp
1.21%
Fund assets

$146.77 Million

Share class

No Load

Morningstar category

Foreign Large Value

Expense ratio

0.51%

Investment objective

Foreign Stock

Documents
    Compare against similar funds*

    * “Similar funds” are top 10 performing funds in the same Morningstar category and share class , defaulted to 5 Year at NAV.